Plant Protein-Derived Bioactive Peptides: From Mechanistic Promise to Health-Promoting Functional Foods
TL;DR
The evidence indicates that peptide discovery should not be treated as the principal endpoint of research, and future progress will require translation-oriented development in which bioactivity, digestion stability, matrix compatibility, sensory quality, manufacturing reproducibility, realistic intake, human evidence, and regulatory credibility are evaluated as interdependent criteria.
Abstract
Plant protein-derived bioactive peptides have attracted increasing interest as potential ingredients for health-promoting functional foods because of their reported cardiometabolic, antioxidant, anti-inflammatory, immunomodulatory, antimicrobial, gastrointestinal, and satiety-related activities. However, the field remains dominated by peptide discovery, in silico prediction, enzyme-inhibition assays, simulated digestion, and preclinical models, whereas successful translation into clinically supported and technologically viable food products is still limited. This review critically examines the gap between mechanistic promise and functional food implementation. It integrates evidence on plant protein sources, peptide-generation strategies, structure–activity relationships, gastrointestinal stability, intestinal transport, local gut activity, food-matrix interactions, processing effects, encapsulation, sensory constraints, human efficacy, regulatory substantiation, commercial feasibility, and consumer acceptance. Particular attention is given to the limited predictive value of isolated in vitro activity when peptides are exposed to digestion, epithelial barriers, complex food matrices, realistic processing conditions, and achievable dietary doses. The review also highlights that systemic absorption is not the only relevant pathway, as selected peptides may act locally within the gastrointestinal tract. Overall, the evidence indicates that peptide discovery should not be treated as the principal endpoint of research. Future progress will require translation-oriented development in which bioactivity, digestion stability, matrix compatibility, sensory quality, manufacturing reproducibility, realistic intake, human evidence, and regulatory credibility are evaluated as interdependent criteria. The most promising plant-derived peptides will therefore be those that retain sufficient activity and acceptability under real conditions of food production and consumption.